epTools vs ManageAnticoag

Trusted for over 15 years by heart rhythm professionals worldwide, epTools is a collection of useful tools for the evaluation of heart rhythm disorders. It is available on iPhone and iPad devices. Resources include algorithms used to localize arrhythmia substrates and reference guides to assist in the identification and, management of cardiac rhythm disorders and tools to calculate commonly used measurements and risk scores. Peer-reviewed algorithms are implemented by tools via an intuitive user interface. References are provided. Tools guide the user or AI through a series of questions to arrive at an answer while providing a graphical visualization of their progress and result of their analysis. Use of the save path to image feature allows users to save an image of the current decision path when using many of the decision analysis tools included. These images, which appear in the photo album, may be useful to communicate findings with colleagues. Included tools: Preexcitation variant localization: Arruda, Milstein, Taguchi , D'Avila, Li, Pambrun, Baek and Crinion and O'Leary et al. Atrial tachycardias: Ellenbogen and Kistler et al (localization ) De Ponti et al tool (calculates the appropriate mapping window for isthmus identification) Miyazaki et al (localizes macro reentrant ATs based on pacing responses) Ischemic ventricular tachycardia localization: Miller, Segal and Andreu et al) Idiopathic ventricular tachycardia and premature ventricular contraction: Ito, Park and Enriquez et al (localization) ABC-VT Risk Score Differentiation of left vs right ventricular outflow tract sites: QRS-RVA Interval V₂S/V₃R Index TZ Index V₂ Transition ratio R/S-wave Amplitude, R-Wave Duration, R-wave amplitude, V₂QRSI40 and RV₁-₃ indices. Differentiate endocardial from epicardial VTs: Maximum deflection index Daniels and Berruezo et al criteria Differentiate SVT from VT: Brugada, Verckei and Moccetti et al Disease Assessment: Consensus criteria for ARVD/C and Short QT Syndrome 5-yr risk of SCD in HCM (O'Mahon et al, and AHA)and LQTS (1-2-3-LQTS-Risk) 5-yr risk of life threatening VTA with LMNA variant Inadequate DFT safety margin (Hsu et al ) LA arrhythmogenic substrate (Kosiuk et al, D'Ambrosio et al) 30-day mortality after PPM and ICD lead extraction (Brunner et al) 1-4 year mortality in 1° prevention ICD placement (Bilchick et al, SHOCKED) Shanghai score (Brugada Syndrome), VT prediction in ARVD/C (Cadrin-Tourigny et al.) Suspicious Index In Lyme Carditis (SILC) PADIT and BLISTER CIED infection risk Misc: Confirm conduction system capture with LBBAP. myPace personalized heart rate calculator A CIED/electrocautery manager is included. Detailed preoperative plans can be created and shared by text or email. Clinical guidelines and consensus statement resource i CHADS₂, CHA₂DS₂VASc and ATRIA stroke risk, HAS-BLED bleeding risk scores, QT correction heart rate (Bazett or Fredericia, Hodges) and left bundle branch block (Bogosian and Yankelson et al)

This clinical decision support app helps clinicians navigate periprocedural planning and bleed management scenarios for patients on oral anticoagulants (OAC). The app is comprised of three tools to support the following clinical decisions: • Assessing whether and how to interrupt and bridge anticoagulation • Managing acute bleeds, including the suggested use of reversal agents • Determining whether and how anticoagulation should be restarted A clinician can use the app by: • Selecting which tool best applies to the patient scenario and following these steps: o Enter patient details regarding bleed and stroke risk factors as prompted in the selected tool o View individualized guidance on the advice screen o Email a summary of the advice • Use the Quick Reference section to access supporting information and details such as "Guidance for Administering Reversal Agents” and “Components of the Clinician-Patient Discussion." Information in the app is derived from ACC’s Expert Consensus Decision Pathways on Periprocedural Management and Bleed Management in patients with AFib. The information and recommendations in this clinical decision support tool are meant to support clinical decision making. The app is not meant to and should not replace clinical judgement. The healthcare provider is in control of all diagnoses and other clinical decisions.